Signal Advisors Wealth LLC grew its position in Oracle Corporation (NYSE:ORCL – Free Report) by 180.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,876 shares of the enterprise software provider’s stock after purchasing an additional 3,784 shares during the quarter. Signal Advisors Wealth LLC’s holdings in Oracle were worth $864,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Perennial Investment Advisors LLC increased its stake in Oracle by 0.5% in the 3rd quarter. Perennial Investment Advisors LLC now owns 9,627 shares of the enterprise software provider’s stock worth $2,708,000 after buying an additional 45 shares in the last quarter. Consolidated Portfolio Review Corp lifted its position in shares of Oracle by 1.0% in the third quarter. Consolidated Portfolio Review Corp now owns 4,988 shares of the enterprise software provider’s stock valued at $1,403,000 after acquiring an additional 50 shares in the last quarter. Mpwm Advisory Solutions LLC lifted its position in shares of Oracle by 76.9% in the third quarter. Mpwm Advisory Solutions LLC now owns 115 shares of the enterprise software provider’s stock valued at $32,000 after acquiring an additional 50 shares in the last quarter. Clarion Wealth Managment Partners LLC boosted its stake in shares of Oracle by 1.5% in the third quarter. Clarion Wealth Managment Partners LLC now owns 3,563 shares of the enterprise software provider’s stock worth $1,002,000 after acquiring an additional 51 shares during the period. Finally, Verum Partners LLC boosted its stake in shares of Oracle by 2.2% in the fourth quarter. Verum Partners LLC now owns 2,409 shares of the enterprise software provider’s stock worth $470,000 after acquiring an additional 51 shares during the period. 42.44% of the stock is owned by hedge funds and other institutional investors.
Oracle Price Performance
NYSE:ORCL opened at $157.38 on Thursday. The business’s 50-day moving average is $190.16 and its 200 day moving average is $176.34. Oracle Corporation has a 12 month low of $134.57 and a 12 month high of $345.72. The company has a market capitalization of $453.34 billion, a P/E ratio of 27.00, a P/E/G ratio of 1.04 and a beta of 1.65. The company has a current ratio of 1.12, a quick ratio of 1.35 and a debt-to-equity ratio of 3.21.
Oracle Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 24th. Investors of record on Friday, July 10th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.3%. The ex-dividend date is Friday, July 10th. Oracle’s payout ratio is currently 34.31%.
Insider Transactions at Oracle
In other Oracle news, EVP Stuart Levey sold 15,000 shares of the stock in a transaction on Thursday, April 16th. The shares were sold at an average price of $176.19, for a total transaction of $2,642,850.00. Following the completion of the transaction, the executive vice president owned 3,429 shares in the company, valued at $604,155.51. This trade represents a 81.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 40.90% of the stock is currently owned by insiders.
Key Stories Impacting Oracle
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle is still being viewed by some analysts as a major AI infrastructure winner, with commentary pointing to a massive AI backlog that could convert into revenue over the next several years. Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Positive Sentiment: Oracle Health announced an AI collaboration with Theator to extend AI into operating rooms, which could support future growth in healthcare workflows, documentation, and billing automation. Oracle Health Extends AI into the Operating Room in Collaboration with Theator
- Neutral Sentiment: Several bullish articles argue Oracle’s recent sell-off may be overdone and that the stock could rebound if backlog conversion and cloud growth continue to improve investor confidence. Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Neutral Sentiment: Oracle’s annual filing and follow-up coverage confirmed the workforce reductions were tied to broader AI adoption, but the company framed them as part of a restructuring effort rather than a sign of operational distress. Oracle Sheds 21,000 Jobs as It Continues AI-Focused Streamlining
- Negative Sentiment: Investors are worried that Oracle’s AI spending is being funded with more debt and that preferred stock conversions or ATM share issuance could dilute shareholders and weigh on the stock price. Oracle Analyst Warns: Preferred Stock Conversions and ATM Issuances May Dilute Shareholders and Pressure Stock Price
- Negative Sentiment: Broader tech weakness and an AI sector pullback are also adding to ORCL’s decline, as investors reassess high-spending AI names. Sector Update: Tech Stocks Fall Late Afternoon
Analyst Ratings Changes
Several analysts recently issued reports on the company. JPMorgan Chase & Co. raised Oracle from a “neutral” rating to an “overweight” rating and decreased their target price for the company from $230.00 to $210.00 in a research note on Wednesday, March 11th. BMO Capital Markets upped their price target on Oracle from $200.00 to $220.00 and gave the stock an “outperform” rating in a research note on Thursday, June 11th. Mizuho set a $320.00 price objective on shares of Oracle in a report on Wednesday, June 3rd. Guggenheim reiterated a “buy” rating and set a $400.00 price objective on shares of Oracle in a research report on Thursday, June 11th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and issued a $190.00 target price on shares of Oracle in a report on Thursday, June 11th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Oracle has a consensus rating of “Moderate Buy” and a consensus target price of $268.27.
View Our Latest Stock Analysis on ORCL
Oracle Profile
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Recommended Stories
- Five stocks we like better than Oracle
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
